Nationwide Fund Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-580,391	Closed	-$10.2M	–	1873
2017 Q3	$10.2M	Sell	580,391 -489,719	-46%	-$11M	0.04%	630
2017 Q2	$35.5M	Buy	1,070,110 +67,675	+7%	+$2.09M	0.14%	134
2017 Q1	$32.2M	Sell	1,002,435 -1,256	-0.1%	-$42.9K	0.13%	165
2016 Q4	$36.4M	Buy	1,003,691 +37,266	+4%	+$1.49M	0.15%	125
2016 Q3	$44.5M	Sell	966,425 -15,931	-2%	-$831K	0.19%	90
2016 Q2	$49.3M	Buy	982,356 +117,506	+14%	+$6.26M	0.21%	78
2016 Q1	$46.5M	Buy	864,850 +200,938	+30%	+$11.8M	0.2%	87
2015 Q4	$43.6M	Buy	663,912 +91,200	+16%	+$5.64M	0.19%	94
2015 Q3	$32.3M	Buy	572,712 +7,174	+1%	+$465K	0.15%	140
2015 Q2	$33.4M	Buy	565,538 +12,224	+2%	+$754K	0.14%	154
2015 Q1	$34.5M	Buy	553,314 +14,188	+3%	+$825K	0.14%	152
2014 Q4	$31M	Buy	539,126 +24,666	+5%	+$1.37M	0.13%	169
2014 Q3	$27.7M	Buy	514,460 +60,574	+13%	+$3.21M	0.12%	194
2014 Q2	$23.8M	Buy	453,886 +109,247	+32%	+$5.58M	0.1%	249
2014 Q1	$18.2M	Sell	344,639 -7,780	-2%	-$360K	0.08%	297
2013 Q4	$14.1M	Sell	352,419 -48,355	-12%	-$1.9M	0.06%	409
2013 Q3	$15.1M	Buy	400,774 +35,396	+10%	+$1.38M	0.07%	357
2013 Q2	$14.3M	Buy	+365,378	New	+$14.2M	0.08%	310